Tag: EMA
-
The Safety of COVID-19 Vaccinations — Should We Rethink the Policy?
Abstract Background: COVID-19 vaccines have had expedited reviews without sufficient safety data. We wanted to compare risks and…
Editor’s Choice
About the Journal
This initiative exists to help insure that policies in public health practice and law are founded on a full consideration of available knowledge derived by robust science. From Dr Lyons-Weiler: “While IPAK will continue to conduct basic, clinical and translational biomedical research in a completely unbiased manner, and will pubish results regardless of the outcome, it will also be increasingly centered on questions of policy and law that impact public health, laws that impact public health, and cases and rulings that impact the citizen’s expression of self-governance through law. We’re putting the Public back into Public Health.”